Chronic dietary supplementation with turmeric protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated neurotoxicity in vivo: Implications for Parkinson's disease

British Journal of Nutrition

Volumn 106, Issue 1, 2011, Pages 63-72

  Mythri, Rajeswara Babu ^a   Veena, Jayagopalan ^a,b   Harish, G ^a   Shankaranarayana Rao, B S ^a   Bharath, M M Srinivas ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b NutriNeuro Bordeaux University   (France)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Mitochondrial complex I; Parkinson's disease; Protein nitration; Turmeric

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 NITROTYROSINE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TURMERIC; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN NERVE CELL; BRAIN PROTECTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; IN VIVO STUDY; MALE; MOUSE; NERVE CELL DEGENERATION; NEUROTOXICITY; NITRATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CURCUMA; DIET; DIETARY SUPPLEMENTS; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; PARKINSON DISEASE; SUBSTANTIA NIGRA;

CURCUMA LONGA; MUS;

EID: 79960113178     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510005817     Document Type: Article

References (55)

1. Burke RE (1998) Parkinson's disease. In Cell Death and Disease of the Nervous System, pp. 459-475 [VE Koliatsos and RR Ratan, editors]. Totowa, NJ: Humana.
2. Bharath MM (2008) Therapeutic strategies in Parkinson's disease. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2, 135-147.
3. Aggarwal BB, Bhatt ID, Ichikawa H, et al. (2006) Curcumin - biological and medicinal properties. In Turmeric: The Genus Curcuma, pp. 297-368. London: Taylor and Francis Group.
4. Goel A, Kunnumakkara AB & Aggarwal BB (2008) Curcumin as 'Curecumin': from kitchen to clinic. Biochem Pharmacol 75, 787-809.
5. Mythri RB, Jagatha B, Pradhan N, et al. (2007) Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid Redox Signal 9, 399-408. (Pubitemid 46145986)
6. Harish G, Venkateshappa C, Mythri RB, et al. (2010) Bioconjugates of curcumin display improved protection against glutathione depletion mediated oxidative stress in a dopaminergic neuronal cell line: implications for Parkinson's disease. Bioorg Med Chem 18, 2631-2638.
7. Jagatha B, Mythri RB, Vali S, et al. (2008) Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic Biol Med 44, 907-917.
8. Ramassamy C (2006) Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 545, 51-64.
9. Ammon HP & Wahl MA (1991) Pharmacology of Curcuma longa. Planta Med 57, 1-7.
10. Anand P, Kunnumakkara AB, Newman RA, et al. (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4, 807-818.
11. Sharma RA, Steward WP & Gescher AJ (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595, 453-470.
12. Balaji S & Chempakam B (2009) Pharmacokinetics prediction and drugability assessment of diphenylheptanoids from turmeric (Curcuma longa L.). Med Chem 5, 130-138.
13. Ortiz-Ortiz MA, Moran JM, Ruiz-Mesa LM, et al. (2010) Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Neurosci Lett 468, 120-124.
14. Ortiz-Ortiz MA, Moran JM, Bravosanpedro JM, et al. (2009) Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species. Neurotoxicology 30, 1008-1018.
15. Tayyem RF, Heath DD, Al-Delaimy WK, et al. (2006) Curcumin content of turmeric and curry powders. Nutr Cancer 55, 126-131. (Pubitemid 44719625)
16. Hou XL, Takahashi K, Kinoshita N, et al. (2007) Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharm 337, 169-177. (Pubitemid 46756042)
17. Ahmed T & Gilani AH (2009) Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine- induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol Biochem Behav 91, 554-559.
18. Seelig GF & Meister A (1985) Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Methods Enzymol 113, 379-390. (Pubitemid 16195807)
19. Paxinos G & Franklin KBJ (2001) The Mouse Brain in Stereotaxic Co-ordinates, 2nd ed. San Diego, CA: Academic Press.
20. Veena J, Srikumar BN, Mahati K, et al. (2009) Enriched environment restores hippocampal cell proliferation and ameliorates cognitive deficits in chronically stressed rats. J Neurosci Res 87, 831-843.
21. Veena J, Srikumar BN, Raju TR, et al. (2009) Exposure to enriched environment restores the survival and differentiation of new born cells in the hippocampus and ameliorates depressive symptoms in chronically stressed rats. Neurosci Lett 455, 178-182.
22. Ebadi M & Sharma SK (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease. Antioxid Redox Signal 5, 319-335. (Pubitemid 36793015)
23. Abeliovich A & Flint Beal M (2006) Parkinsonism genes: culprits and clues. J Neurochem 99, 1062-1072. (Pubitemid 44655273)
24. Cicchetti F, Drouin-Ouellet J & Gross RE (2009) Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol Sci 30, 475-483.
25. Mattson MP (2003) Gene-diet interactions in brain aging and neurodegenerative disorders. Ann Intern Med 139, 441-444. (Pubitemid 38120873)
26. Bharucha NE, Bharucha EP, Bharucha AE, et al. (1988) Prevalence of Parkinson's disease in the Parsi community of Bombay, India. Arch Neurol 45, 1321-1323.
27. Muthane U, Yasha TC & Shankar SK (1998) Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 43, 283-287. (Pubitemid 28113589)
28. Alladi PA, Mahadevan A, Yasha TC, et al. (2009) Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease. Neuroscience 159, 236-245.
29. Ragothaman M, Murgod UA, Gururaj G, et al. (2003) Lower risk of Parkinson's disease in an admixed population of European and Indian origins. Mov Disord 18, 912-914. (Pubitemid 37021166)
30. Platel K & Srinivasan K (2004) Digestive stimulant action of spices: a myth or reality? Indian J Med Res 119, 167-179. (Pubitemid 38811839)
31. Srinivasan K (2005) Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr 56, 399-414. (Pubitemid 43135377)
32. Sinha R, Anderson DE, McDonald SS, et al. (2003) Cancer risk and diet in India. J Postgrad Med 49, 222-228. (Pubitemid 37493414)
33. Anand P, Sundaram C, Jhurani S, et al. (2008) Curcumin and cancer: an 'old-age' disease with an 'age-old' solution. Cancer Lett 267, 133-164.
34. Kim SJ, Son TG, Park HR, et al. (2008) Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 283, 14497-14505.
35. Xu Y, Ku B, Cui L, et al. (2007) Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 1162, 9-18. (Pubitemid 47088372)
36. Lalitha S & Selvam R (1999) Prevention of H2O2-induced red blood cell lipid peroxidation and hemolysis by aqueous extracted turmeric. Asia Pac J Clin Nutr 8, 113-114.
37. Sarhan R, El-Azim SA, Motawi TM, et al. (2007) Protective effect of turmeric, Ginkgo biloba, Silymarin separately or in combination, on iron-induced oxidative stress and lipid peroxidation in rats. Int J Pharmacol 3, 375-384. (Pubitemid 351330635)
38. Wang J, Du XX, Jiang H, et al. (2009) Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 78, 178-183.
39. Beal MF (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 15, Suppl. 3, S189-S194.
40. Pal R, Cristan EA, Schnittker K, et al. (2010) Rescue of ER oxidoreductase function through polyphenolic phytochemical intervention: implications for subcellular traffic and neurodegenerative disorders. Biochem Biophys Res Commun 392, 567-571.
41. Yang S, Zhang D, Yang Z, et al. (2008) Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res 33, 2044-2053.
42. Calabrese V, Guagliano E, Sapienza M, et al. (2006) Redox regulation of cellular stress response in neurodegenerative disorders. Ital J Biochem 55, 263-282.
43. Sawada H, Ibi M, Kihara T, et al. (2002) Estradiol protects dopaminergic neurons in a MPP \+ Parkinson's disease model. Neuropharmacology 42, 1056-1064. (Pubitemid 34786558)
44. Yu S, Zheng W, Xin N, et al. (2010) Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway. Rejuvenation Res 13, 55-64.
45. Rajeswari A & Sabesan M (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16, 96-99. (Pubitemid 351521747)
46. Chen J, Tang XQ, Zhi JL, et al. (2006) Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11, 943-953. (Pubitemid 43876825)
47. Zbarsky V, Datla KP, Parkar S, et al. (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 39, 1119-1125. (Pubitemid 41358566)
48. Pandey N, Strider J, Nolan WC, et al. (2008) Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol 115, 479-489.
49. Li W, Wang S, Feng J, et al. (2009) Structure elucidation and NMR assignments for curcuminoids from the rhizomes of Curcuma longa. Magn Reson Chem 47, 902-908.
50. Zeng Y, Qiu F, Takahashi K, et al. (2007) New sesquiterpenes and calebin derivatives from Curcuma longa. Chem Pharm Bull (Tokyo) 55, 940-943. (Pubitemid 46890101)
51. Kim DS, Park SY & Kim JK (2001) Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci Lett 303, 57-61. (Pubitemid 32285467)
52. Kim DS & Kim JY (2001) Total synthesis of Calebin-A, preparation of its analogues, and their neuronal cell protectivity against beta-amyloid insult. Bioorg Med Chem Lett 11, 2541-2543. (Pubitemid 32823351)
53. Park SY & Kim DS (2002) Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. J Nat Prod 65, 1227-1231.
54. Schiborr C, Eckert GP, Rimbach G, et al. (2010) A validated method for the quantification of curcumin in plasma and brain tissue by fast narrow-bore high-performance liquid chromatography with fluorescence detection. Anal Bioanal Chem 397, 1917-1925.
55. Suresh D & Srinivasan K (2010) Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J Med Res 131, 682-691.